Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc ONCY


Primary Symbol: T.ONC

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and... see more

TSX:ONC - Post Discussion

View:
Post by pelaboost on Aug 14, 2024 6:27pm

Warrants

If you look at the first quarter of 2024, there were 8,267.778 common share purchase warrants outstanding. That may not have been mentioned in the second quarter 2024 report.

We need to know the date of the financing for the 3.5 million warrants that appear to have expired.

Cheers
Comment by spesestsemper on Aug 14, 2024 6:36pm
If you add up the three warrant groups you get the 8,267,778 . 
Comment by pelaboost on Aug 14, 2024 6:49pm
Just out of curiosity are the 3.5 million in that 8,267,778. I used to track this stuff, but am not following as closely these days. Waiting for Cohort 5. TIA and Good Luck.
Comment by spesestsemper on Aug 14, 2024 6:58pm
No - i do not believe so
Comment by pelaboost on Aug 14, 2024 7:21pm
I think you may be right. There were almost 7.000.000 warrants in the July 2023 financing. One might assume the 3.5 were exercised. It does not really matter. Looking at these actions speaks to the sloppiness and questionable moves on many fronts in the past. Before the boo birds jump on this post, please note I am soon to be a cautious buyer. I like Cantor on hand. I like the new guy. I ...more  
Comment by Noteable on Aug 14, 2024 7:40pm
None of the July 2023 warrants were exercised.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities